Potential IPO candidate BioNTech secures $325 million in financing round
FRANKFURT (Reuters) – German biotech firm BioNTech has secured $325 million in a private financing round to boost its cancer immunotherapies pipeline, the company said on Tuesday. Two-thirds of the…